Dicyclohexylphthalate causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity

Journal of Neurochemistry

Volumn 91, Issue 1, 2004, Pages 69-76

  Ishido, Masami ^a   Masuo, Yoshinori ^b   Sayato Suzuki, Junko ^a   Oka, Syuichi ^b   Niki, Etsuo ^b   Morita, Masatoshi ^a  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Dicyclohexylphthalate; DNA array; Endocrine disrupters; Hyperactivity; Tyrosine hydroxylase

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; GLUTAMATE RECEPTOR; PHTHALIC ACID DERIVATIVE; PHTHALIC ACID DICYCLOHEXYL ESTER; RECEPTOR SUBTYPE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; CELL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENZYME DEGRADATION; GABAERGIC TRANSMISSION; GENE EXPRESSION; HYPERACTIVITY; IMMUNOREACTIVITY; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; CELL COUNT; CELL DEATH; CORPUS STRIATUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPERKINESIS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MESENCEPHALON; NEUROTOXINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PERIODICITY; PHTHALIC ACIDS; PREGNANCY; RATS; RATS, WISTAR; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; RATTUS NORVEGICUS;

EID: 4744373352     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02696.x     Document Type: Article

References (47)

1. Agency for Toxic Substances and Disease Registry (ATSDR). (2003) Toxicological Profile for di(2-ethylhexyl) phthalate. Agency for Toxic Substances and Disease Registry, Atlanta, GA, USA.
2. Behl C. (2002) Oestrogen as a neuroprotective hormone. Nat. Rev. Neurosci. 3, 433-442.
3. Borges C. R., Geddes T., Watson J. T. and Kuhn D. M. (2002) Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylase inhibition during oxidative stress. J. Biol. Chem. 277, 48295-48302.
4. Center for the Evalution of Risks to Human Reproduction (CERHR). (2000) NTP-CERHR Expert Panel Report on di(2-ethylhexyl) phthalate. Science International Inc., Alexandria, VA, USA.
5. Chen C., Rainnie D. G., Greene R. W. and Tonegawa S. (1994) Abnormal fear response and aggressive behavior in mutant mice deficient for α-calcium-calmodulin kinase II. Science 266, 291-294.
6. Corton J. C., Anderson S. P. and Staube A. (2000) Central role of peroxisome proliferators-activated receptors in the actions of peroxisome proliferators. Ann. Rev. Pharmacol. Toxicol. 40, 491-518.
7. Crawley J. N. (2000) What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice. Wiley-Liss, New York.
8. Davids E., Zhang K., Kula N. S., Tarazi F. I. and Baldessarini R. J. (2002) Effects of norepinephrine and serotonin transputer inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats. J. Pharmacol. Exp. Ther. 301, 1097-1102.
9. Dluzen D. (1997) Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res. 767, 340-344.
10. Elia J., Ambrosini P. J. and Rapoport J. (1999) Treatment of attention deficit hyperactivity disorder. N. Eng. J. Med. 340, 780-788.
11. Frith U. (2002) Mind blindness and the brain in autism. Neuron 32, 969-979.
12. Gerber D., Sotnikova T. D., Gainetdinov R. R., Huang S. Y., Caron M. and Tonegawa S. (2001) Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc. Natl Acad. Sci. USA 98, 15312-15317.
13. Giros B., Jaber M., Jones S. R., Wightman R. M. and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
14. Goldman L. S., Genel M., Bezman R. J. and Slanetz P. J. (1998) Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 279, 1100-1107.
15. Grumolato L., Elkahloun A. G., Ghzili H. et al. (2003) Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. Endocrinology 144, 2368-2379.
16. Hsu S. M. and Raine L. (1981) Protein A, avidin, and biotin in immunohistochemistry. J. Histochem. Cytochem. 29, 1309-1351.
17. Ishido M. and Suzuki S. J. (2003) Epitope-tagged metallothionein: its biochemical and immunocytochemical applications. J. Health Sci. 49, 156-159.
18. Ishido M., Homma-Takeda S. and Suzuki T. (1998) Apoptosis in rat renal proximal tubular cells induced by cadmium. J. Toxicol. Environ. Health 55, 1-12.
19. 1 cells. J. Pharmacol Exp. Ther. 290, 923-928.
20. Ishido M., Nina H. and Kabuto M. (2001) Magnetic fields (MF) of 50 HZ. and 1.2 μT as well as 100 μT cause uncoupling of inhibitory pathways of adenylyl cyclase mediated by melatonin 1 a receptor in MF-sensitive MCF-7 cells. Carcinogenesis 22, 1043-1048.
21. Ishido M., Masuo Y., Oka S., Kunimoto M. and Morita M. (2002) Application of Supermex system to screen behavioral traits produced by tributyltin in the rat. J. Health Sci. 48, 451-454.
22. Ishido M., Masuo Y., Kunimoto M., Oka S. and Morita M. (2004) Bisphenol A causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J. Neurosci. Res. 76, 423-433.
23. Jacobson M. (1991) Developmental Neurobiology. Plenum Press, New York.
24. Jacobson J. L. and Jacobson S. W. (1996) Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N. Engl. J. Med. 335, 783-789.
25. Jiang M., Gold M. S., Boulay G., Spicher K., Peyton M., Brabet P., Srinivasan Y., Rudolph U., Ellison G. and Bimbaumer L. (1998) Multiple neurological abnormalities in mice deficient in the G protein Go. Proc. Natl Acad. Sci. USA 95, 3269-3274.
26. Kamimura E., Ueno Y., Tanaka S., et al. (2001) New rat model for attention deficit hyperactive disorder (ADHD). Comparative Med. 51, 245-251.
27. Kubota Y., Inagaki S., Kito S. and Wu J.-Y. (1987) Dopaminergic axons directly make synapses with GABAergic neurons in the rat neostriatum. Brain Res. 406, 147-156.
28. LaHoste G. J., Swanson J. M., Wigal S. B., Galbe C., Wigal T., King N. and Kennedy J. (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatry 1, 121-124.
29. Lyons W. E., Mamounas L. A., Ricaurte G. A., Coppola V., Reid S. W., Bora S. H., Wihler C., Koliatsos V. E. and Tessarollo L. (1999) Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc. Natl Acad. Sci. USA 96, 15239-15244.
30. Masuo Y., Matsumoto Y., Morita S. and Noguchi J. (1997) A novel method for counting spontaneous motor activity in the rat. Brain Res. Protocols 1, 321-326.
31. Masuo Y., Ishido M., Morita M. and Oka S. (2002) Effects of neonatal 6-hydroxydopamine lesion on the gene expression profile in young adult rats. Neurosci. Lett. 335, 124-128.
32. Miyakawa T., Yamada M., Duttaroy A. and Wess J. (2001) Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J. Neurosci. 21, 5239-5250.
33. Mylchreest E., Cattley R. C. and Foster P. M. (1998) Male reproductive tract malformations in rats following gestational and lactational exposure to di(n-butyl) phthalate: an antiandrogenic mechanism? Toxicol. Sci. 43, 47-60.
34. NTP (National Toxicology Program). (1998) Report on carcinogens, eight edition. National Toxicology Program: National Institutes of Health (NIH) publications, Research Triangle Park, NC, USA.
35. Okubo T., Suzuki T., Yokoyama Y., Kano K. and Kano I. (2003) Estimation of estrogenic and anti-estrogenic activities of some phthalatediesters and monoesters by MCF-7 cell proliferation assay in vitro. Biol. Pharm. Bull. 26, 1219-1224.
36. 1A receptor. Proc. Natl Acad. USA 95, 10734-10739.
37. Patandin S., Lanting C. I., Mulder P. G., Boersma E. R., Sauer P. J. and Weisglas-Kuperus N. (1999) Effects of environmental exposure to polychlorinated biphenyls and dioxins on cognitive abilities in Dutch children at 42 months of age. J. Pediatr. 134, 33-41.
38. Rice D. C. and Barone S. Jr (2000) Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Persp. 108, 511-533.
39. Shaywitz B. A., Yager R. D. and Klopper J. H. (1976) Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191, 305-308.
40. Stein D. G. (2001) Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci. 24, 386-391.
41. Tabacova S., Little R. and Balabaeva L. (1999) Maternal exposure to phthalates and complications of pregnancy. Epidemiology 10, S127.
42. Tyl R. W., Price C. J., Marr M. C. and Kimmel C. A. (1988) Developmental toxicity evalution of dietary di(2-ethylhexyl) phthalate in Fischer 344rats and CD-1 mice. Fundam. Appl. Toxicol. 10, 395-412.
43. Vaudry D., Chen Y., Ravni A., Hamelink C., Elkahloun A. G. and Eiden L. E. (2002) Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP). J. Neurochem. 83, 1272-1284.
44. Vorhees C. V. (1986) Principles of behavioral teratology, in Handbook of Behavioral Teratology (Riley, E. P., Vorhees, C. V., eds). pp. 23-48, Plenum Press, New York, USA.
45. Wilson C. J. and Kawaguchi Y. (1996) The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J. Neurosci. 16, 2397-2410.
46. Wittmann M., Marino M. J., Bradley S. R. and Conn P. J. (2001) Activation of group III mGluRs inhibits GABA-ergic and glutamatergic transmission in the substantia nigra pars reticulate. J. Neurophysiol. 85, 1960-1968.
47. Xu M., Koeltzow T. E., Santiago G. T., Moratalla R., Cooper D. C., Hu X.-T., White N. M., Graybiel A. M., White F. J. and Tonegawa S. (1997) Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Cell 19, 837-848.